Leveraging Non-negative Matrix Tri-Factorization and Knowledge-Based Embeddings for Drug Repurposing: an Application to Parkinson's Disease

Author:

Messa Letizia1ORCID,Testa Carolina1ORCID,Carelli Stephana2ORCID,Rey Federica3ORCID,Cereda Cristina2ORCID,Raimondi Manuela Teresa4ORCID,Ceri Stefano1ORCID,Pinoli Pietro1ORCID

Affiliation:

1. Department of Electronics,Information and Bioengineering (DEIB), Politecnico di Milano, Italy

2. Center of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, Italy

3. Pediatric Clinical Research Center "Fondazione Romeo ed Enrica Invernizzi", DIBIC, University of Milan, Italy

4. Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Italy

Publisher

ACM

Reference40 articles.

1. Alexander Aliper, Sergey Plis, Artem Artemov, Alvaro Ulloa, Polina Mamoshina, and Alex Zhavoronkov. 2016. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Molecular pharmaceutics 13, 7 (2016), 2524–2530.

2. Han Altae-Tran, Bharath Ramsundar, Aneesh S Pappu, and Vijay Pande. 2017. Low data drug discovery with one-shot learning. ACS central science 3, 4 (2017), 283–293.

3. Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

4. Non-negative Matrix Tri-Factorization for Data Integration and Network-based Drug Repositioning

5. Matrix Factorization-based Technique for Drug Repurposing Predictions

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3